Sign in
CompletedNo phase

The 5Ad Diet for Functional Bowel Disorders

Key facts

Who runs it
University of Suffolk
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
52 people enrolled
Started
8 May 2022
Ended
1 Apr 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • The 5Ad Diet
  • The Low FODMAP Diet
Record updated
24 November 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Individuals are eligible for the study if all of the following criteria are met:
  • Suffers chronically from either constipation, diarrhoea, or an alternation of both, bloating, flatulence or abdominal pain, incomplete defecation, straining and bowel urgency
  • Symptoms must be present for ≥ 2 times per week, with symptom onset occurring at least 3 months prior to participation
  • Participants taking prescribed medications which may affect bowel function are included only if the intake is maintained throughout the entire intervention period

Who cannot take part

  • History of abdominal/gastrointestinal surgery within 1 year prior to participation
  • History of antibiotic use in the last 6 weeks prior to participation
  • Known underlying pathology (e.g., Crohn's disease, ulcerative colitis, celiac disease)
  • Allergic to the foods specified in both the 5Ad diet and the low FODMAP diet
  • Individuals are excluded from the study if any of the following criteria are met:
  • Pregnant

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this randomised controlled trial (RCT) is to compare the efficacy of the newly developed 5Ad diet against the widely researched low fermentable oligo-, di-, monosaccharide and polyols (FODMAP) diet in reducing gastrointestinal symptoms associated with functional bowel disorders/food intolerances.

Read full original descriptionShow less

The primary aims of this RCT are to determine:

* Whether the 5Ad diet is at least as effective as the low FODMAP diet in reducing gastrointestinal symptoms associated with FBDs/food intolerances. * Whether either the 5Ad diet or the low FODMAP diet are effective in reducing mental and physical fatigue.

To achieve the above aims, an RCT will be conducted with the 5Ad diet in one arm vs the active phase of the low FODMAP diet in the other arm, in a cross-over design with a 7 days washout phase in between. Both dietary protocols will be followed by each participant for 7 days.

Researchers will compare the results from the 2 dietary protocols in order to ascertain the superiority of one over the other in regards to 6 gastrointestinal symptoms (abdominal pain, bloating, flatulence, bowel urgency, straining and incomplete defecation), stool form and frequency of defecation.

The 2 groups in the trial

  • The 5Ad DietExisting treatment, for comparison

    Participants are required to follow the 5Ad diet for 7 days, followed by a washout phase for 7 days, before crossing over to the active phase of the low FODMAP diet for 7 days.

    Treatment: The 5Ad Diet and The Low FODMAP Diet

  • The Low FODMAP DietExisting treatment, for comparison

    Participants are required to follow the active phase of the low FODMAP diet for 7 days, followed by a washout phase for 7 days, before crossing over to the 5Ad diet for 7 days.

    Treatment: The 5Ad Diet and The Low FODMAP Diet

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The 5Ad Diet for Functional Bowel Disorders: A Randomised Controlled Trial Against the Low FODMAP Diet
Record updated
24 November 2025